beta-sitosterol sulfate: internal standard for measuement of cholesteryl sulfate; RN given refers to (3beta)-isomer
ID Source | ID |
---|---|
PubMed CID | 3037102 |
SCHEMBL ID | 395699 |
MeSH ID | M0102076 |
Synonym |
---|
stigmast-5-en-3-beta-ol, hydrogen sulfate |
stigmast-5-en-3-ol, hydrogen sulfate, (3beta)- |
24-beta-ethylcholest-5-en-3-beta-ol sulfate |
cholest-5-en-3-beta-ol, 24-beta-ethyl-, sulfate salt (1:1) |
beta-sitosterol sulfate |
beta-sitosteryl sulfate |
stigmast-5-en-3-ol, hydrogen sulfate, (3-beta)- |
sitosterol sulfate |
beta-sitosteryl sulphate |
[(3s,8s,9s,10r,13r,14s,17r)-17-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate |
24815-93-8 |
unii-b3tpl6g216 |
b3tpl6g216 , |
SCHEMBL395699 |
.beta.-sitosteryl sulfate |
.beta.-sitosterol-3-o-sulfate |
stigmast-5-en-3-ol, 3-(hydrogen sulfate), (3.beta.)- |
24.xi.-ethylcholest-5-en-3.beta.-ol sulfate |
.beta.-sitosterol sulfate |
Q27274322 |
stigmast-5-en-3-yl hydrogen sulfate |
DTXSID00947729 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.68) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |